IP Verse

Baxalta Incorporated opposition analysis

COMPANY ANALYSIS

Latest patents of Baxalta Incorporated opposed by its competitors

Patent:
EP3064508
Grant Date:
Mar 15, 2023
Title:
Method Of Producing Recombinant High Molecular Weight Vwf In Cell Culture
Oppositions:
1
Patent:
EP3521422
Grant Date:
Oct 6, 2021
Title:
Substantially Animal Protein-Free Recombinat Furin And Methods For Producing Same
Oppositions:
1
Patent:
EP3277718
Grant Date:
Mar 24, 2021
Title:
Dosage Regimen For Anti-Mif Antibodies
Oppositions:
1
Patent:
EP3121266
Grant Date:
Apr 22, 2020
Title:
Oligopeptide-Free Cell Culture Media
Oppositions:
6
Patent:
EP2739641
Grant Date:
Apr 15, 2020
Title:
Systems And Methods To Increase Protein Yield From Recombinant Manufacturing Processes
Oppositions:
1
Patent:
EP3116534
Grant Date:
May 29, 2019
Title:
Compositions Of Human Prothrombin And Activated Factor X For Improving Hemostasis In The Treatment Of Bleeding Disorders
Oppositions:
1
Patent:
EP2652491
Grant Date:
Nov 29, 2017
Title:
Eluate Collection Using Conductivity Gradient
Oppositions:
1
Patent:
EP2295547
Grant Date:
Sep 20, 2017
Title:
Recombinant Co-Expression Of Vitamin K Epoxide Reductase Subunit 1 To Improve Vitamin K Dependant Protein Expression
Oppositions:
1
Patent:
EP1974014
Grant Date:
Apr 19, 2017
Title:
Oligopeptide-Free Cell Culture Media
Oppositions:
6

Competitors of Baxalta Incorporated

STRAWMAN LIMITED

ALCONADA RODRIGUEZ, AGUSTIN

APTEVO BIOTHERAPEUTICS LLC

Want to track Baxalta Incorporated?

Feel free to send us a message here and we will get back to you